The non-disintegrating buccal film will not dissolve when it comes into contact with saliva, and the APIs are continuously released under control. It is developed as a promising dosage form, which has prominent advantages because of drug delivery through the buccal mucosa. CD Formulation has many years of experience in the development of oral thin films, and our professional technical teams and advanced development platform can efficiently develop the non-disintegrating buccal film.
Fig.1 Rizatriptan loaded hydrogel-based mucoadhesive buccal film. (Shery Jacob, et al., 2021)
During the formulation design phase of the non-disintegrating film, we need to focus on the adhesion testing, our team of experts will evaluate the suitability of excipients and adhesion properties so that some new copolymers can be selected as biomimetics for adhesion tests more cost-effectively. In addition, we also pay attention to the compatibility of film formers, plasticizers, masking technologies, and APIs to achieve the characteristics of the desired non-disintegrating buccal film properties.
We focus on the performance testing and safety evaluation of buccal film. We select the appropriate casting technology based on the properties and characteristics of the non-disintegrating buccal film. At the same time, we also analyze many aspects to ensure the applicability of the method.
Our oral thin film technology platform is equipped with the world's top brands of equipment, including an X-ray powder diffractometer, Raman spectrometer, thermogravimetric differential thermal meter, gas adsorption detector, texture meter, rheometer, high-performance liquid chromatography, vacuum emulsion tank, electrostatic spinning machine, coating machine, and scutter, etc., in the entire development and production process to implement strict quality control.
In the whole process of pilot development, pilot scale, and commercial production of oral thin film preparations, we can realize all-round control of key process parameters of non-disintegrating buccal film.
Technologies | Specifics Contents |
Microencapsulate Technology | This encapsulation technology is used in particular for products and ingredients for the food industry. Our technical teams microencapsulate drugs that are difficult to accept, such as bitter taste, into some pH-sensitive polymers to achieve good taste masking and improve patient compliance. |
Solvent Evaporation Technology | Solvent evaporation involves emulsification of polymer in aqueous phase and dispersion in a volatile solvent like dichloromethane, chloroform, and ethyl acetate. Then the solvent is evaporated using high temperature, vacuum, or by continuous stirring. |
Solvent Extraction Technology | Solvent extraction is a classical analytical technique used to determine the contents of various inorganic and organic species. Inorganic compounds are usually extracted after complexation with organic ligands. |
Technology: Solvent Casting technology
Journal: International Journal of Pharmaceutics
IF: 5.8
Published: 2021
Results: In this study, biomimetic materials were evaluated as a replacement for buccal mucosa in mucoadhesion testing and potential adhesives were compared regarding their suitability to increase the adhesion of hypromellose-based oromucosal films. Gelatin gels, as possible biomimetics, failed to mimic the buccal mucosa.
Fig.2 Development of buccal film formulations and their mucoadhesive performance in biomimetic models. (Anja Göbel, et al., 2021)
Relying on the advanced technology platform and professional research and development team, CD Formulation constantly overcomes difficulties and explores innovations to provide effective development solutions for non-disintegrating buccal film drug delivery systems. If you have any requirements about our non-disintegrating buccal film development services, please contact us by phone or email, our colleagues will reply to you within three working days.
References